Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Pharyngitis Treatment Market Valuation Change Between Now And 2029?
In recent times, there has been a consistent expansion in the pharyngitis treatment market size. It is projected to escalate from $2.27 billion in 2024 to $2.37 billion in 2025, with a compound annual growth rate (CAGR) of 4.2%. The growth observed in the historic period is due to the high occurrence and increasing incidents of flu, mounting prevalence of pharyngitis, the increase in awareness about pharyngitis, better access to healthcare facilities, and increasing disposable incomes.
The market for pharyngitis treatment is forecasted to experience robust expansion in the upcoming years, growing to $3 billion by 2029 with an annual compound growth rate (CAGR) of 6.1%. This growth trajectory in the projected period is due to factors such as the uptake of rapid point-of-care tests, the demand for personalized medical treatments, increasing instances of antibiotic resistance, and the growing emphasis on hand hygiene. Key trends to watch during this forecast period include the progression in pharyngitis treatment research, digital health technology improvements, and the integration of telehealth.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp
What Underlying Factors Are Supporting The Pharyngitis Treatment Market Growth?
An increment in cases of strep throat transmission is predicted to spur the progression of the pharyngitis treatment market. Being a contagious bacterial infection, strep throat predominantly influences the throat and tonsils. Swift and efficient treatment of this infection with antibiotics can alleviate symptoms, ward off potential complications, and curtail the likelihood of transmitting the infection to others. For example, in June 2022, data from the Centers for Disease Control and Prevention, a government agency in the United States, revealed that an estimated 14,000 to 25,000 cases of invasive group A strep disease are reported annually in the US. Moreover, strep diseases result in 5.2 million outpatient visits and necessitate 2.8 million antibiotic prescriptions every year. Hence, the escalating transmission of strep throat fuels the growth of the pharyngitis treatment market.
Which Sub-Segments Are Driving Growth Within The Pharyngitis Treatment Market?
The pharyngitis treatmentmarket covered in this report is segmented –
1) By Drug Class: Beta Lactams; Macrolides; Cephalosporins; Fluoroquinolones; Tetracycline; Other Drug Classes
2) By Source of Infection: Viral; Bacterial
3) By Modes Of Delivery: Oral; Intravenous; Intramuscular; Other Modes Of Delivery
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Beta Lactams: Penicillins; Amoxicillin; Ampicillin
2) By Macrolides: Erythromycin; Azithromycin; Clarithromycin
3) By Cephalosporins: Cefuroxime; Ceftriaxone; Cefdinir
4) By Fluoroquinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin
5) By Tetracycline: Doxycycline; Minocycline; Tetracycline
6) By Other Drug Classes: Clindamycin; Sulfonamides; Carbapenems
What Current And Upcoming Trends Are Shaping The Pharyngitis Treatment Market?
Leading corporations engaged in the pharyngitis treatment market are channeling their focus towards the evolution of innovative solutions such as oral monotherapy. This approach aims to boost patient adherence by providing effective and convenient therapeutic options. Oral monotherapy signifies the oral administration of a singular medicinal drug to battle a particular disease or condition. This therapy style employs only one therapeutic agent instead of a combination of them to deliver the sought-after curative effect. For example, in December 2023, Novartis AG, a Switzerland-based pharmaceutical corporation secured FDA approval for Fabhalta (iptacopan), establishing it as the first-ever oral monotherapy for adults suffering from paroxysmal nocturnal hemoglobinuria (PNH). This achievement hit its mark on [date], symbolizing a substantial breakthrough by offering a new treatment that improves hemoglobin levels and eradicates the necessity for blood transfusions.
Which Companies Hold A Competitive Edge In The 721 Market?
Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report
Which Region Dominates The Pharyngitis Treatment Market Today?
North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12937&type=smp
Browse Through More Reports Similar to the Global Pharyngitis Treatment Market 2025, By The Business Research Company
Inflammatory Bowel Disease Treatment Global Market Report 2025
Non Steroidal Anti Inflammatory Drugs Global Market Report 2025
Cystic Fibrosis Cf Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
